YU48997A - Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje - Google Patents
Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanjeInfo
- Publication number
- YU48997A YU48997A YU48997A YU48997A YU48997A YU 48997 A YU48997 A YU 48997A YU 48997 A YU48997 A YU 48997A YU 48997 A YU48997 A YU 48997A YU 48997 A YU48997 A YU 48997A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- leu
- ser
- thr
- ile
- val
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Child & Adolescent Psychology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Opisani su novi proteini formule I 5 10 Val Pro Ile Gln Lys Val Gln Asp Asp Thr Lys Thr Leu 15 Ile Lys Thr 20 25 30 Ile Val Thr Arg Ile Xaa Asp Ile Ser His Thr Xaa Ser Val Ser Ser 35 40 45 Lys Gln Lys Val Thr Gly Leu Asp Phe Ile Pro Gly Leu His Pro Ile 50 55 60 Leu Thr Leu Ser Lys Met Asp Gln Thr Leu ALa Val Tyr Gln Gln Ile 65 70 75 Leu Thr Ser Met Pro Ser Arg Xaa Xaa Ile Gln Ile Ser 80 Asn Asp Leu 85 90 95 Glu Asn Leu Arg Asp Leu Leu His Val Leu Ala Phe Ser Lys Ser Cys 100 105 110 His Leu Pro Trp Ala Ser Gly Leu Glu Thr Leu Asp Ser Leu Gly Gly 115 120 125 Val Leu Glu Ala Ser Gly Tyr Ser Thr Glu Val Val Ala Leu Ser Arg 130 135 140 Leu Gln Gly Ser Leu Gln Asp Met Leu Trp Gln Leu Asp Leu Ser Pro 145 Gly Cys (SEQ ID NO: 1) (I) ili njihove farmaceutski prihvatljive soli. Takodje su opisane farmaceutske smese koje kao aktivni sastojak koriste proteine formule I kao i postupak za dobijanje tih proteina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3356196P | 1996-12-20 | 1996-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU48997A true YU48997A (sh) | 1999-09-27 |
Family
ID=21871119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU48997A YU48997A (sh) | 1996-12-20 | 1997-12-18 | Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0849276A1 (sh) |
| JP (1) | JPH10179158A (sh) |
| KR (1) | KR19980064258A (sh) |
| CN (1) | CN1194986A (sh) |
| AR (1) | AR013886A1 (sh) |
| AU (2) | AU4843297A (sh) |
| BR (1) | BR9706358A (sh) |
| CA (1) | CA2217698A1 (sh) |
| CO (1) | CO4700343A1 (sh) |
| CZ (1) | CZ407097A3 (sh) |
| HU (1) | HUP9702500A3 (sh) |
| ID (1) | ID19257A (sh) |
| IL (1) | IL122569A0 (sh) |
| NO (1) | NO975938L (sh) |
| NZ (1) | NZ329413A (sh) |
| PE (1) | PE47599A1 (sh) |
| PL (1) | PL323956A1 (sh) |
| SG (1) | SG65040A1 (sh) |
| SV (1) | SV1997000107A (sh) |
| TR (1) | TR199701666A2 (sh) |
| WO (1) | WO1998028335A1 (sh) |
| YU (1) | YU48997A (sh) |
| ZA (1) | ZA9710877B (sh) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ525021A (en) | 1997-04-15 | 2004-05-28 | Csir | Pharmaceutical compositions having appetite suppressant activity |
| WO1999044598A2 (en) * | 1998-03-03 | 1999-09-10 | Board Of Regents, The University Of Texas System | Methods for inhibiting βcell apoptosis |
| GB9924484D0 (en) * | 1999-10-15 | 1999-12-15 | Isis Innovation | Altered polypeptide aggregation |
| GB2396815B (en) | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
| US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
| GB2363985B (en) | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| CN101336110B (zh) | 2006-06-01 | 2011-06-01 | 程云 | 预防或治疗肝损伤的肽及其衍生物及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5827734A (en) * | 1995-01-20 | 1998-10-27 | University Of Washington | Materials and methods for determining ob protein in a biological sample |
| CA2211664A1 (en) * | 1995-01-31 | 1996-08-08 | Eli Lilly And Company | Anti-obesity proteins |
| AU4862396A (en) * | 1995-02-06 | 1996-08-27 | Eli Lilly And Company | Human obesity gene |
| AU5539596A (en) * | 1995-04-06 | 1996-10-23 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
| GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
| JPH11508134A (ja) * | 1995-06-22 | 1999-07-21 | イーライ・リリー・アンド・カンパニー | 肥満症蛋白質中間体およびその製法と使用 |
-
1997
- 1997-12-02 CA CA002217698A patent/CA2217698A1/en not_active Abandoned
- 1997-12-03 ZA ZA9710877A patent/ZA9710877B/xx unknown
- 1997-12-11 IL IL12256997A patent/IL122569A0/xx unknown
- 1997-12-16 NZ NZ329413A patent/NZ329413A/en unknown
- 1997-12-16 CO CO97073281A patent/CO4700343A1/es unknown
- 1997-12-16 EP EP97310190A patent/EP0849276A1/en not_active Withdrawn
- 1997-12-16 PE PE1997001122A patent/PE47599A1/es not_active Application Discontinuation
- 1997-12-16 BR BR9706358A patent/BR9706358A/pt not_active Application Discontinuation
- 1997-12-16 SV SV1997000107A patent/SV1997000107A/es unknown
- 1997-12-17 CZ CZ974070A patent/CZ407097A3/cs unknown
- 1997-12-17 AR ARP970105941A patent/AR013886A1/es unknown
- 1997-12-17 KR KR1019970069938A patent/KR19980064258A/ko not_active Application Discontinuation
- 1997-12-17 AU AU48432/97A patent/AU4843297A/en not_active Abandoned
- 1997-12-17 NO NO975938A patent/NO975938L/no not_active Application Discontinuation
- 1997-12-18 SG SG1997004559A patent/SG65040A1/en unknown
- 1997-12-18 CN CN97129705A patent/CN1194986A/zh active Pending
- 1997-12-18 AU AU53846/98A patent/AU5384698A/en not_active Abandoned
- 1997-12-18 HU HU9702500A patent/HUP9702500A3/hu unknown
- 1997-12-18 WO PCT/US1997/023344 patent/WO1998028335A1/en active Search and Examination
- 1997-12-18 ID IDP973915A patent/ID19257A/id unknown
- 1997-12-18 YU YU48997A patent/YU48997A/sh unknown
- 1997-12-18 PL PL97323956A patent/PL323956A1/xx unknown
- 1997-12-18 JP JP9349102A patent/JPH10179158A/ja not_active Withdrawn
- 1997-12-19 TR TR97/01666A patent/TR199701666A2/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR013886A1 (es) | 2001-01-31 |
| CO4700343A1 (es) | 1998-12-29 |
| PL323956A1 (en) | 1998-06-22 |
| TR199701666A3 (tr) | 1999-10-21 |
| AU4843297A (en) | 1998-06-25 |
| ZA9710877B (en) | 1999-06-03 |
| AU5384698A (en) | 1998-07-17 |
| EP0849276A1 (en) | 1998-06-24 |
| HUP9702500A2 (hu) | 1998-07-28 |
| PE47599A1 (es) | 1999-05-14 |
| CA2217698A1 (en) | 1998-06-20 |
| NO975938D0 (no) | 1997-12-17 |
| CN1194986A (zh) | 1998-10-07 |
| SG65040A1 (en) | 1999-05-25 |
| WO1998028335A1 (en) | 1998-07-02 |
| KR19980064258A (ko) | 1998-10-07 |
| NO975938L (no) | 1998-06-22 |
| JPH10179158A (ja) | 1998-07-07 |
| HUP9702500A3 (en) | 1999-07-28 |
| TR199701666A2 (xx) | 1999-10-21 |
| IL122569A0 (en) | 1998-06-15 |
| BR9706358A (pt) | 1999-05-04 |
| HU9702500D0 (en) | 1998-03-02 |
| SV1997000107A (es) | 1999-01-18 |
| CZ407097A3 (cs) | 1998-07-15 |
| ID19257A (id) | 1998-06-28 |
| NZ329413A (en) | 1999-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU5396A (sh) | Novi biološki aktivni proteini, njihove farmaceutske formulacije i postupak za njihovo dobijanje | |
| DE59007517D1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung. | |
| YU71395A (sh) | Acilovani analozi insulina | |
| NZ502872A (en) | Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| KR970015598A (ko) | 환상 결합 억제제 | |
| HUP0003592A2 (hu) | LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények | |
| NO911854D0 (no) | Fremgangsmaate for fremstilling av peptid-derivater. | |
| MX9602259A (es) | Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion. | |
| ZA952086B (en) | Heterocyclic compounds their preparation and use | |
| MXPA02001340A (es) | Compuestos novedosos 1,4-benzodiazepina y derivados de los mismos. | |
| YU394A (sh) | Novi peptidi koji deluju kao antagonisti opijatskih receptora i postupci za njihovu izradu | |
| AU2003264708A1 (en) | Use of aspartic proteases in cosmetics and therapeutics | |
| MX9710252A (es) | Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento. | |
| WO1998037100A3 (en) | Therapeutic use of the smr1 protein and active derivatives thereof | |
| YU29596A (sh) | Genski proizvodi koji regulišu gojaznost | |
| YU48997A (sh) | Novi biološki aktivni proteini, njihove farmaceutske smeše i postupak za njihovo dobijanje | |
| CA2002924A1 (en) | Anti-Thrombins | |
| EP0277626A3 (en) | Synthetic ghrh analogs | |
| NO941151L (no) | Lineære adhesjonsinhibitorer | |
| AU1377092A (en) | Peptides for treatment | |
| NZ334714A (en) | Liver proteins as agents against autoimmune diseases | |
| NO975565L (no) | Benstimulerende faktor | |
| HUP0003357A2 (hu) | Angiogén hatású ciklusos azapeptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények, eljárás ezek előállítására és alkalmazásuk | |
| HUP9902415A2 (hu) | Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására |